TrialAmerican journal of hematology2026

Hetrombopag Added to Cyclosporine as the First-Line Treatment for Patients With Non-Severe Aplastic Anemia: A Phase 2 Multicenter Trial.

Lele Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.